These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Meeting notes from ICAAC. Tenofovir + emtricitabine vs. AZT + 3TC. Feinberg J AIDS Clin Care; 2005 Jan; 17(1):7. PubMed ID: 15717373 [No Abstract] [Full Text] [Related]
13. The durability of virological success of tenofovir and didanosine dosed at either 400 or 250 mg once daily. Tung MY; Mandalia S; Bower M; Gazzard B; Nelson M HIV Med; 2005 May; 6(3):151-4. PubMed ID: 15876280 [TBL] [Abstract][Full Text] [Related]
14. 96-week CASTLE data show similar efficacy results. AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840 [No Abstract] [Full Text] [Related]
15. Tenofovir: FDA hearing on important new antiretroviral. James JS AIDS Treat News; 2001 Oct; (372):2-4. PubMed ID: 11702411 [No Abstract] [Full Text] [Related]
16. Tenofovir DF on the horizon. Investigational nucleotide reverse transcriptor inhibitor could be on pharmacy shelves soon. Eagan L Posit Living; 2001; 10(5):21. PubMed ID: 11693102 [No Abstract] [Full Text] [Related]
17. Would switching the protease inhibitors (PI) to tenoforvir be an option in controlling hypertriglyceridaemia secondary to PIs? A case report. Alcaide ML; Kolber M; Jayaweera D Int J STD AIDS; 2002 Nov; 13(11):795-6. PubMed ID: 12437905 [No Abstract] [Full Text] [Related]
18. Upcoming compassionate use programs for two new antiretrovirals will begin this fall. Schouten J STEP Perspect; 1999; 99(3):16. PubMed ID: 11366864 [TBL] [Abstract][Full Text] [Related]
19. Kidney damage reported in some tenofovir users. TreatmentUpdate; 2003; 15(2):6-7. PubMed ID: 12693362 [No Abstract] [Full Text] [Related]
20. Partial immunological and mitochondrial recovery after reducing didanosine doses in patients on didanosine and tenofovir-based regimens. Negredo E; Garrabou G; Puig J; Lòpez S; Morén C; Bellido R; Ayen R; Cardellach F; Miró O; Clotet B Antivir Ther; 2008; 13(2):231-40. PubMed ID: 18505174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]